Study Evaluates Use of Milvexian in Secondary Stroke Prevent

The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.

Related Keywords

Australia , Switzerland , Jenny Jiang , Priyanka Gaitonde , Merena Henderson , Meg Crighton , Graemej Hankey , National Institute Of Health Stroke Scale , Stroke Research , University Of Western Australia , National Institutes Of Health Stroke Score , Program Co , European Stroke Organization Conference , Perron Institute , Bristol Myers Squibb , Johnson , Perron Institute Chair , Western Australia , National Institute , Health Stroke Scale , National Institutes , Health Stroke Score , Librexia Stroke , Score Among Patients , Factor Xla Inhibition , Coagulation Biomarkers ,